FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/21/2025
Back to search
Official data from USPTO
EUROMED PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
04/03/2026
Trademark type
Combined
Nice classes
35, 42
Filing date
11/05/2021
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "EUROMED PHARMA" in capital letters with the word "EUROMED" in blue and the word "PHARMA" in red. All preceded by a blue circumference cut horizontally by a wavy red line.
Holders and representatives
Holders
EUROMED S.R.L.
Representatives
Anthony P. Venturino Vorys, Sater, Seymour and Pease LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Reseller servicesdistributorship services in the fields of pharmaceuticalscosmetics and nutritional supplements; import agency services in the field of pharmaceuticalscosmetics and nutritional supplements; wholesale distributorship services featuring pharmaceuticalscosmetics and nutritional supplements; business management of logistics for others in the field of pharmaceuticalscosmetics and nutritional supplements
Class 42
clinical research in the field of pharmaceuticals; providing medical and scientific research information in the field of clinical research
Publications
History of USPTO decisions and trademark events.
37 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/01/2025
FIMP
FINAL DISPOSITION PROCESSED
01/31/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
GPNX
NOTIFICATION PROCESSED BY IB
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/15/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/11/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/13/2023
GNFR
FINAL REFUSAL E-MAILED
10/13/2023
CNFR
FINAL REFUSAL WRITTEN
10/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/09/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/09/2023
RFNT
REFUSAL PROCESSED BY IB
04/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/13/2023
RFRR
REFUSAL PROCESSED BY MPU
03/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/18/2023
CNRT
NON-FINAL ACTION WRITTEN
01/17/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
10/24/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/31/2022
CNRT
NON-FINAL ACTION WRITTEN
08/30/2022
DOCK
ASSIGNED TO EXAMINER
08/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/03/2022
Continuous trademark protection
Get notified about every new filing that threatens EUROMED PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.